Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea

American Journal of Hypertension

Volumn 16, Issue 4, 2003, Pages 274-280

  Møller, Dorthe Svenstrup ^a   Lind, Pernille ^b   Strunge, Benedicte ^b   Pedersen, Erling B ^b  

^a HOLSTEBRO HOSPITAL   (Denmark)

^b NONE

Author keywords

24 h ambulatory blood pressure; Aldosterone; Angiotensin II; Continuous positive airway pressure; Hypertension; Renin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; HORMONE; RENIN; VASOACTIVE AGENT; VASOPRESSIN;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HOLTER MONITORING; HORMONE DETERMINATION; HUMAN; HYPERTENSION; HYPOTHESIS; MALE; NATRIURESIS; PLASMA RENIN ACTIVITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SLEEP APNEA SYNDROME; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

EID: 0037381920     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03267-3     Document Type: Article

References (33)

1. Koskenvou M, Kaprio J, Partinen M, Langinvainio H, Sarna S, Heikkila K: Snoring as a risk factor for hypertension and angina pectoris. Lancet 1985;ii:893-896.
2. Koskenvou M, Kaprio J, Telakivi T, Partinen M, Heikkila K, Sarna S: Snoring as a risk factor for ischaemic heart disease and stroke in men. BMJ 1987;294:16-19.
3. Grote L, Ploch T, Heitmann J, Knaack L, Penzel T, Peter JH: Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999;160:1875-1882.
4. Lavie P, Herer P, Hoffstein V: Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479-482.
5. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-1384.
6. Davies CWH, Crosby JH, Mullins RL, Barbour C, Davies RJO, Stradling JR: Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000;55:736-740.
7. Lavie P, Yoffe N, Berger I, Peled R: The relationship between the severity of sleep apnea syndrome and 24-h blood pressure values in patients with obstructive sleep apnea. Chest 1993;103:717-721.
8. Pankow W, Nabe B, Lies A, Becker H, Köhler U, Kohl FV, Lohmann FW: Influence of sleep apnea on 24-hour blood pressure. Chest 1997;112:1253-1258.
9. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J: Sleep apnea and hypertension. A population-based study. Ann Intern Med 1994;120:382-388.
10. Somers VK, Dyken ME, Clary MP, Abboud FM: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-1904.
11. Garcia-Rio F, Racionero MA, Pino JM, Martinez I, Ortuño F, Villasante C, Villamor J: Sleep apnea and hypertension. The role of peripheral chemoreceptors and the sympathetic system. Chest 2000;117:1417-1425.
12. Fletcher EC, Bao G, Li R: Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 1999;34:309-314.
13. Ichioka M, Hirata Y, Inase N, Tojo N, Yoshizawa M, Chida M, Miyazato I, Taniai S, Marumo F: Changes of circulating atrial natriuretic peptide and antidiuretic hormone in obstructive sleep apnea syndrome. Respiration 1992;59:164-168.
14. Follenius M, Krieger J, Krauth MO, Sforza F, Brandenberger G: Obstructive sleep apnea treatment:peripheral and central effects on plasma renin activity and aldosterone. Sleep 1991;14:211-217.
15. Rodenstein DO, D'Odemont JP, Pieters T, Aubert-Tulkens G: Diurnal and nocturnal diuresis and natriuresis in obstructive sleep apnea. Am Rev Respir Dis 1992;145:1367-1371.
16. Saarelainen S, Hasan J, Siitonen S, Seppala E: Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-hour blood pressure in obstructive sleep apnoea. J Sleep Res 1996;5:181-185.
17. Faccenda JF, Mackay TW, Boon NA, Douglas NJ: Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;163:344-348.
18. Sanner BM, Tepel M, Markmann A, Zidek W: Effect of continuous positive airway pressure in patients with obstructive sleep apnea syndrome. Am J Hypertens 2002;15:251-257.
19. Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJO: Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-210.
20. Pedersen EB, Eiskjær H, Madsen B, Danielsen H, Egeblad M, Nielsen CB: Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein ratio in patients with arterial hypertension and unilateral renal artery disease. Nephrol Dial Transplant 1993;8:1064-1070.
21. Kappelgaard AM, Damkjær-Nielsen M, Giese J: Measurement of angiotensin II in human plasma: technical modification and practical experience. Clin Chim Acta 1976;67:299-306.
22. Rask-Madsen J, Bruunsgaard A, Munck O, Nielsen MD, Worning H: The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal bypass operation. Scand J Gastroenterol 1974;9:417-426.
23. Thomassen AR, Bagger JP, Nielsen TT, Pedersen EB: Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease. Int J Cardiol 1987;17:267-276.
24. Jensen KT, Carstens J, Ivarsen P, Pedersen EB: A new, fast and reliable radioimmunoassay for brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997;57:529-540.
25. Pedersen EB, Danielsen H, Spencer ES: Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in essential hypertension. Eur J Clin Pharmacol 1984;26:543-547.
26. O'Brien E, Staessen J: Normotension and hypertension as defined by 24-hour ambulatory blood pressure monitoring. Blood Press 1995;4:266-282.
27. Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C: Variability between current definitions of 'normal' ambulatory blood pressure: implications in the assessment of white coat hypertension. Hypertension 1992;20:555-562.
28. Slutsky AS, Rebuck AS: Heart response to isocapnic hypoxia in conscious man. Am J Physiol Heart Circ Physiol 1978;234:H129-H132.
29. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G: Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801.
30. Kannel WB, Kannel C, Paffenbarger RSJ, Cupples LA: Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489-1494.
31. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ: Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in "non-dippers." Sleep 1996;19:378-381.
32. Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Horie T: Nasal continuous positive airway pressure changes blood pressure "non-dippers" to "dippers" in patients with obstructive sleep apnea. Sleep 1999;22:849-853.
33. Kraiczi H, Hedner J, Peker Y, Carlson J: Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000;89:493-498.